Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
-
Published:2022-05
Issue:5
Volume:10
Page:1202-1216.e23
-
ISSN:2213-2198
-
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
-
language:en
-
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice
Author:
Porsbjerg Celeste M., Menzies-Gow Andrew N., Tran Trung N., Murray Ruth B., Unni Bindhu, Audrey Ang Shi Ling, Alacqua Marianna, Al-Ahmad Mona, Al-Lehebi Riyad, Altraja Alan, Belevskiy Andrey S., Björnsdóttir Unnur S., Bourdin Arnaud, Busby John, Canonica G. Walter, Christoff George C., Cosio Borja G., Costello Richard W., FitzGerald J. Mark, Fonseca João A., Hansen Susanne, Heaney Liam G., Heffler Enrico, Hew Mark, Iwanaga Takashi, Jackson David J., Kocks Janwillem W.H., Kallieri Maria, Bruce Ko Hsin-Kuo, Koh Mariko Siyue, Larenas-Linnemann Désirée, Lehtimäki Lauri A., Loukides Stelios, Lugogo Njira, Maspero Jorge, Papaioannou Andriana I., Perez-de-Llano Luis, Pitrez Paulo Márcio, Popov Todor A., Rasmussen Linda M., Rhee Chin Kook, Sadatsafavi Mohsen, Schmid Johannes, Siddiqui Salman, Taillé Camille, Taube Christian, Torres-Duque Carlos A., Ulrik Charlotte, Upham John W., Wang Eileen, Wechsler Michael E., Bulathsinhala Lakmini, Carter Victoria, Chaudhry Isha, Eleangovan Neva, Hosseini Naeimeh, Rowlands Mari-Anne, Price David B.ORCID, van Boven Job F.M.
Subject
Immunology and Allergy
Reference29 articles.
1. Biological treatments for severe asthma: a major advance in asthma care;Busse;Allergol Int,2019 2. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial;Bleecker;Lancet,2016 3. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials;Castro;Lancet Respir Med,2015 4. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma;Castro;N Engl J Med,2018 5. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|